Beyondspring Inc Share Price Today: Live Updates & Key Insights

Beyondspring Inc share price today is $1.57, up 2.56%. The stock opened at $1.59 against the previous close of $1.56, with an intraday high of $1.59 and low of $1.59.

Beyondspring Inc Share Price Chart

Beyondspring Inc

us-stock
To Invest in {{usstockname}}
us-stock

Beyondspring Inc Share Price Performance

$1.57 0.0256(2.56%) BYSI at 23 Mar 2026 12:21 PM Biotechnology
Lowest Today 1.59
Highest Today 1.59
Today’s Open 1.59
Prev. Close 1.56
52 Week High 3.44
52 Week Low 0.98
Day’s Range: Low 1.59 High 1.59
52-Week Range: Low 0.98 High 3.44
1 day return -
1 Week return -10.67
1 month return +27.2
3 month return -18.46
6 month return -10.16
1 year return -3.63
3 year return +34.74
5 year return -87.35
10 year return -

Beyondspring Inc Institutional Holdings

Decheng Capital LLC 10.42

Vanguard Group Inc 1.85

BlackRock Inc 1.56

Geode Capital Management, LLC 0.90

Vanguard Institutional Extnd Mkt Idx Tr 0.84

Vanguard Total Stock Mkt Idx Inv 0.63

Fidelity Extended Market Index 0.39

iShares Micro-Cap ETF 0.19

Northern Trust Corp 0.17

Fidelity Total Market Index 0.16

Spartan Extended Market Index Pool F 0.13

Blackrock Extended Mkt Fund CF 0.12

Extended Equity Market Fund K 0.10

Fidelity Series Total Market Index 0.10

Northern Trust Extended Eq Market Idx 0.07

NT Ext Equity Mkt Idx Fd - L 0.07

Tanaka Capital Management Inc 0.06

Spartan Total Market Index Pool G 0.06

Fidelity Nasdaq Composite Index 0.06

Vanguard Instl Ttl Stck Mkt Idx Tr 0.06

NT Ext Equity Mkt Idx Fd - NL 0.05

Susquehanna International Group, LLP 0.05

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.04

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.03

Jane Street Group LLC 0.03

Renaissance Technologies Corp 0.03

Morgan Stanley - Brokerage Accounts 0.02

Bank of America Corp 0.02

1290 VT Micro Cap K 0.01

AVIP BlackRock Advtg Small Cp Gr Prtfl 0.01

Northern Small Cap Core I 0.01

NATIONAL BANK OF CANADA /FI/ 0.01

Trifecta Capital Advisors LLC 0.00

UBS Group AG 0.00

JPMorgan Chase & Co 0.00

Tower Research Capital LLC 0.00

Rockefeller Capital Management L.P. 0.00

Advisor Group Holdings, Inc. 0.00

SBI Securities Co Ltd 0.00

BNP Paribas Arbitrage, SA 0.00

Beyondspring Inc Market Status

Strong Buy: 1

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Beyondspring Inc Fundamentals

Market Cap 83.08 M

PB Ratio 5.3811

PE Ratio 0.0

Enterprise Value 52.34 M

Total Assets 34.32 M

Volume 22043

Beyondspring Inc Company Financials

Annual Revenue FY23:1751000 1.8M, FY22:1351000 1.4M, FY21:1351000 1.4M, FY20:180000 0.2M, FY19:0 0.0M

Annual Profit FY23:1751000 1.8M, FY22:1351000 1.4M, FY21:1351000 1.4M, FY20:180000 0.2M, FY19:null 0.0M

Annual Net worth FY23:-21026000 -21.0M, FY22:-36280000 -36.3M, FY21:-68208000 -68.2M, FY20:-61062000 -61.1M, FY19:-38291000 -38.3M

Quarterly Revenue Q3/2025:0 0.0M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q2/2024:500000 0.5M, Q1/2024:500000 0.5M

Quarterly Profit Q3/2025:-21000 -0.0M, Q2/2025:null 0.0M, Q1/2025:-80000 -0.1M, Q2/2024:500000 0.5M, Q1/2024:500000 0.5M

Quarterly Net worth Q3/2025:-1540000 -1.5M, Q2/2025:-1806000 -1.8M, Q1/2025:4477000 4.5M, Q2/2024:-3631000 -3.6M, Q1/2024:-3631000 -3.6M

About Beyondspring Inc & investment objective

Company Information BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on the development of cancer therapies. It operates through two segments: Plinabulin pipeline and TPD platform. The company's lead asset is the Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical trials for treatment of non-small cell lung cancer (NSCLC); and as an anti-cancer agent, as well as for the prevention of chemotherapy-induced neutropenia. It is also developing Plinabulin in combination with docetaxel vs. docetaxel alone for the treatment of NSCLC and epidermal growth factor receptor wild type. In addition, the company develops Plinabulin in combination with various immuno-oncology agents and chemotherapy and radiation; nivolumab, a PD-1 antibody that is has completed phase 1 clinical trials for the treatment of non-small cell lung cancer; ipilimumab, a CTLA-4 antibody for the treatment of extensive-stage small cell lung cancer; in combination with PD-1 or PD-L1 antibodies and radiation for the treatment of various cancers; and pembrolizumab, etoposide, and platinum to treat extensive-stage small cell lung cancer. Further, it engages in the development of three small molecule immune agents in preclinical stages; and a drug discovery platform to develop therapeutic agents from internal research and development efforts and from collaboration. The company was founded in 2010 and is headquartered in Florham Park, New Jersey.

Organisation Biotechnology

Employees 40

Industry Biotechnology

CEO Dr. Lan Huang Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Beyondspring Inc FAQs

What is the share price of Beyondspring Inc today?

The current share price of Beyondspring Inc is $1.57.

Can I buy Beyondspring Inc shares in India?

Yes, Indian investors can buy Beyondspring Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Beyondspring Inc shares in India?

You can easily invest in Beyondspring Inc shares from India by:

Can I buy fractional shares of Beyondspring Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Beyondspring Inc?

Beyondspring Inc has a market cap of $83.08 M.

In which sector does Beyondspring Inc belong?

Beyondspring Inc operates in the Biotechnology sector.

What documents are required to invest in Beyondspring Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Beyondspring Inc?

The PE ratio of Beyondspring Inc is N/A and the PB ratio is 5.38.